These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28332724)

  • 1. Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis.
    Broccoli A; Argnani L; Stefoni V; Gandolfi L; Zinzani PL
    Hematol Oncol; 2018 Feb; 36(1):136-143. PubMed ID: 28332724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study.
    Michallet M; Luporsi E; Soubeyran P; Amar NA; Boulanger V; Carreiro M; Dourthe LM; Labourey JL; Lepille D; Maloisel F; Mouysset JL; Nahon S; Narciso B; Nouyrigat P; Radji R; Sakek N; Albrand H;
    BMC Cancer; 2014 Jul; 14():503. PubMed ID: 25011615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B; van de Werf PR; Melissant CF; Brok RG
    Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
    Patton J; Kuzur M; Liggett W; Miranda F; Varsos H; Porter L
    Oncologist; 2004; 9(1):90-6. PubMed ID: 14755018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study.
    Santini D; Vincenzi B; La Cesa A; Virzi V; Navajas F; Malafarina V; Dicuonzo G; Cassandro R; Esposito V; Montesarchio V; Groeger AM; Tonini G
    Anticancer Res; 2005; 25(1B):669-74. PubMed ID: 15816644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer.
    Thatcher N; De Campos ES; Bell DR; Steward WP; Varghese G; Morant R; Vansteenkiste JF; Rosso R; Ewers SB; Sundal E; Schatzmann E; Stocker H
    Br J Cancer; 1999 May; 80(3-4):396-402. PubMed ID: 10408844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of erythropoiesis-stimulating agents among chemotherapy patients with hemoglobin exceeding 12 grams per deciliter.
    Nordstrom BL; Luo W; Fraeman K; Whyte JL; Nordyke RJ
    J Manag Care Pharm; 2008; 14(9):858-69. PubMed ID: 19006442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer.
    Ariganello O; Mancuso A; Di Molfetta M; Diana F; Beccaglia P; Cortesi E; De Marinis F
    Lung Cancer; 2004 Oct; 46(1):119-24. PubMed ID: 15364140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years.
    Jacobs C; Frei D; Perkins AC
    Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii3-24. PubMed ID: 15824128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended epoetin alfa dosing in chronic kidney disease patients: a retrospective review.
    Germain M; Ram CV; Bhaduri S; Tang KL; Klausner M; Curzi M
    Nephrol Dial Transplant; 2005 Oct; 20(10):2146-52. PubMed ID: 15985516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.
    Leyland-Jones B; Semiglazov V; Pawlicki M; Pienkowski T; Tjulandin S; Manikhas G; Makhson A; Roth A; Dodwell D; Baselga J; Biakhov M; Valuckas K; Voznyi E; Liu X; Vercammen E
    J Clin Oncol; 2005 Sep; 23(25):5960-72. PubMed ID: 16087945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy.
    Schouwink JH; Codrington H; Sleeboom HP; Kerkhofs LG; Wormhoudt LW
    Eur J Cancer; 2008 Apr; 44(6):819-29. PubMed ID: 18343652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retacrit®, Biosimilar of Epoetin Alfa, in Chemotherapy-Induced Anemia in Routine Practice: Impact of Iron Supplementation.
    Laribi K; Spaeth D; Scotte F; Ray-Coquard I
    Oncology; 2022; 100(10):519-528. PubMed ID: 35051930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose reduction of epoetin-alpha in the prevention of chemotherapy-induced anaemia.
    Lüthi F; Pless M; Leyvraz S; Biedermann B; Müller E; Hermann R; Monnerat C
    Support Care Cancer; 2010 Dec; 18(12):1515-20. PubMed ID: 19921283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of epoetin zeta in the treatment of chemotherapy-induced anaemia.
    Tzekova V; Mihaylov G; Elezovic I; Koytchev R;
    Curr Med Res Opin; 2009 Jul; 25(7):1689-97. PubMed ID: 19505200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early intervention with epoetin beta prevents severe anaemia in patients with solid tumours receiving platinum-based chemotherapy: results of the NeoPrevent study.
    de Castro J; Ordóñez A; Isla D; Sánchez A; Arrivi A; Manzano JL; Barón MG
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):35-42. PubMed ID: 16874498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy.
    Shasha D; George MJ; Harrison LB
    Cancer; 2003 Sep; 98(5):1072-9. PubMed ID: 12942577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
    Abdelrazik N; Fouda M
    Hematology; 2007 Dec; 12(6):533-41. PubMed ID: 17852440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.